Posted in | News | Quantum Dots

Quantum Materials Awarded Patent for Continuous Synthesis of High Quality Nanoparticles

Quantum Materials Corp today announced that the United States Patent and Trademark Office has granted Quantum Materials Corp Patent # 9577149 for the continuous synthesis of high quantum yield InP/ZnS nanocrystals.

“This is an important milestone in consolidating and protecting our intellectual property for large scale volume synthesis of non-cadmium quantum dots,” Quantum Materials founder and CEO Stephen Squires stated. “Continuous synthesis micro-reaction technology is the solution for synthesis of high-quality nanoparticles due to the many advantages our patented process provides, including precise temperature control, mixing efficiencies, fast reaction speed and parallel operation for scalable volume production.”

United States Patent # 9577149 (available at this LINK) covers the continuous-flow synthesis process for the preparation of high quality indium phosphide/zinc sulfide core/shell semiconducting nanocrystals - in particular quantum dots (QD) -  conducted in a micro-reaction system comprising at least one mixing chamber connected to one reaction chamber.

“We have begun continuous-flow volume production of high-efficiency blue quantum dots that we believe will play an important role in the future of quantum dot light-emitting diodes (QD-LEDs). Prior to this point, blue quantum dots exhibited unfavorable energy levels in comparison to red and green quantum dots with respect to device efficiency,” Mr. Squire concluded.

Source: http://www.qmcdots.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.